BRIEF-Vexim says Anvisa approves Spinejack implants in Brazil
* HAS RECEIVED REGULATORY APPROVAL FROM ANVISA(1), BRAZIL'S NATIONAL HEALTH SURVEILLANCE AGENCY, IN ORDER TO COMMERCIALIZE SPINEJACK® IN BRAZIL.
March 27 Jiangzhong Pharmaceutical Co Ltd :
* Says it plans to to pay cash div 4 yuan per 10 shares for FY 2016
Source text in Chinese: goo.gl/m8DaQQ
Further company coverage: (Beijing Headline News)
SAO PAULO, May 29 Brazilian healthcare services provider Notre Dame Intermédica Sistema de Saúde SA on Monday filed for regulatory clearance to launch an initial public offering, the latest in a wave of stock listings in Latin America's largest economy after a years-long drought.